TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Kemal Catakovic; Franz Josef Gassner; Christoph Ratswohl; Nadja Zaborsky; Stefan Rebhandl; Maria Schubert; Markus Steiner; Julia Christine Gutjahr; Lisa Pleyer; Alexander Egle; Tanja Hartmann; Richard Greil; Roland Geisberger

doi:10.1080/2162402X.2017.1371399

TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Kemal Catakovic (First author), Franz Josef Gassner (Co-author), Christoph Ratswohl, Nadja Zaborsky (Co-author), Stefan Rebhandl, Maria Schubert, Markus Steiner (Co-author), Julia Christine Gutjahr (Co-author), Lisa Pleyer (Co-author), Alexander Egle (Co-author), Tanja Hartmann (Co-author), Richard Greil (Co-author), Roland Geisberger^* (Last author)

^*Corresponding author for this work

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Original Article (Journal) › peer-review

57 Citations (Web of Science)

Original language	English
Pages (from-to)	e1371399
Journal	ONCOIMMUNOLOGY
Volume	7
Issue number	1
DOIs	https://doi.org/10.1080/2162402X.2017.1371399
Publication status	Published - 2017

Keywords

INTERFERON-GAMMA
VIRAL-INFECTION
NK CELLS
CD4(+)
CANCER
IMMUNOGLOBULIN
CD155
CLL
LENALIDOMIDE
CYTOTOXICITY

Access to Document

10.1080/2162402X.2017.1371399

Cite this

Catakovic, K., Gassner, F. J., Ratswohl, C., Zaborsky, N., Rebhandl, S., Schubert, M., Steiner, M., Gutjahr, J. C., Pleyer, L., Egle, A., Hartmann, T., Greil, R., & Geisberger, R. (2017). TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia. ONCOIMMUNOLOGY, 7(1), e1371399. https://doi.org/10.1080/2162402X.2017.1371399

@article{5385aa463284448aa7c71e028bc190ce,

title = "TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.",

keywords = "INTERFERON-GAMMA, VIRAL-INFECTION, NK CELLS, CD4(+), CANCER, IMMUNOGLOBULIN, CD155, CLL, LENALIDOMIDE, CYTOTOXICITY",

author = "Kemal Catakovic and Gassner, {Franz Josef} and Christoph Ratswohl and Nadja Zaborsky and Stefan Rebhandl and Maria Schubert and Markus Steiner and Gutjahr, {Julia Christine} and Lisa Pleyer and Alexander Egle and Tanja Hartmann and Richard Greil and Roland Geisberger",

note = "Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.",

year = "2017",

doi = "10.1080/2162402X.2017.1371399",

language = "English",

volume = "7",

pages = "e1371399",

journal = "ONCOIMMUNOLOGY",

issn = "2162-402X",

number = "1",

}

TY - JOUR

T1 - TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

AU - Catakovic, Kemal

AU - Gassner, Franz Josef

AU - Ratswohl, Christoph

AU - Zaborsky, Nadja

AU - Rebhandl, Stefan

AU - Schubert, Maria

AU - Steiner, Markus

AU - Gutjahr, Julia Christine

AU - Pleyer, Lisa

AU - Egle, Alexander

AU - Hartmann, Tanja

AU - Greil, Richard

AU - Geisberger, Roland

N1 - Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Paracelsus Medical University, Salzburg, Austria.

PY - 2017

Y1 - 2017

KW - INTERFERON-GAMMA

KW - VIRAL-INFECTION

KW - NK CELLS

KW - CD4(+)

KW - CANCER

KW - IMMUNOGLOBULIN

KW - CD155

KW - CLL

KW - LENALIDOMIDE

KW - CYTOTOXICITY

U2 - 10.1080/2162402X.2017.1371399

DO - 10.1080/2162402X.2017.1371399

M3 - Original Article (Journal)

C2 - 29296521

SN - 2162-402X

VL - 7

SP - e1371399

JO - ONCOIMMUNOLOGY

JF - ONCOIMMUNOLOGY

IS - 1

ER -